OPKO Health, Inc., 10% Owner at Sorrento Therapeutics, Inc. (SRNE), sold 9,355 shares at $7.75 ($73K) on 2013-09-04, disclosed to the SEC on 2013-09-04.
Open-market sale of $73k SRNE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.75 | 9,300 | $72K | 99.4% |
| 2 | $8.01 | 55 | $441 | 0.6% |
| Total | $7.75 avg | 9,355 | $73K | 100% |
| Filing → |
| WGS | SELL | 2024-08-08 | $3.9M | — | Filing → |
| WGS | SELL | 2024-08-02 | $6.0M | — | Filing → |
| WGS | SELL | 2024-07-31 | $1.7M | — | Filing → |